Darzalex SC (daratumumab)

pCPA File Number: 21759

Negotiation Status:

Concluded with an LOI

Indication(s):

Light chain amyloidosis (AL), newly diagnosed in adult patients (in combination with bortezomib, cyclophosphamide, and dexamethasone)

Sponsor/Manufacturer:

Janssen Inc.

CDA-AMC Project Number:

PC0257-000

pCPA Engagement Letter Issued:

2022-03-04

Negotiation Process Concluded:

2022-03-11